Copyright Reports & Markets. All rights reserved.

Global Absorbable Drug Eluting Coronary Stent System Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Absorbable Drug Eluting Coronary Stent System Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Rapamycin Eluting Stent
    • 1.3.3 Everolimus Eluting Stent
    • 1.3.4 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Absorbable Drug Eluting Coronary Stent System Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Hospitals
    • 1.4.3 Clinic
    • 1.4.4 Others
  • 1.5 Global Absorbable Drug Eluting Coronary Stent System Market Size & Forecast
    • 1.5.1 Global Absorbable Drug Eluting Coronary Stent System Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Absorbable Drug Eluting Coronary Stent System Sales Quantity (2020-2031)
    • 1.5.3 Global Absorbable Drug Eluting Coronary Stent System Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Boston Scientific
    • 2.1.1 Boston Scientific Details
    • 2.1.2 Boston Scientific Major Business
    • 2.1.3 Boston Scientific Absorbable Drug Eluting Coronary Stent System Product and Services
    • 2.1.4 Boston Scientific Absorbable Drug Eluting Coronary Stent System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Boston Scientific Recent Developments/Updates
  • 2.2 Medtronic
    • 2.2.1 Medtronic Details
    • 2.2.2 Medtronic Major Business
    • 2.2.3 Medtronic Absorbable Drug Eluting Coronary Stent System Product and Services
    • 2.2.4 Medtronic Absorbable Drug Eluting Coronary Stent System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Medtronic Recent Developments/Updates
  • 2.3 Abbott
    • 2.3.1 Abbott Details
    • 2.3.2 Abbott Major Business
    • 2.3.3 Abbott Absorbable Drug Eluting Coronary Stent System Product and Services
    • 2.3.4 Abbott Absorbable Drug Eluting Coronary Stent System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Abbott Recent Developments/Updates
  • 2.4 B.Braun
    • 2.4.1 B.Braun Details
    • 2.4.2 B.Braun Major Business
    • 2.4.3 B.Braun Absorbable Drug Eluting Coronary Stent System Product and Services
    • 2.4.4 B.Braun Absorbable Drug Eluting Coronary Stent System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 B.Braun Recent Developments/Updates
  • 2.5 BD
    • 2.5.1 BD Details
    • 2.5.2 BD Major Business
    • 2.5.3 BD Absorbable Drug Eluting Coronary Stent System Product and Services
    • 2.5.4 BD Absorbable Drug Eluting Coronary Stent System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 BD Recent Developments/Updates
  • 2.6 Biotronik AG
    • 2.6.1 Biotronik AG Details
    • 2.6.2 Biotronik AG Major Business
    • 2.6.3 Biotronik AG Absorbable Drug Eluting Coronary Stent System Product and Services
    • 2.6.4 Biotronik AG Absorbable Drug Eluting Coronary Stent System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Biotronik AG Recent Developments/Updates
  • 2.7 Stentys SA
    • 2.7.1 Stentys SA Details
    • 2.7.2 Stentys SA Major Business
    • 2.7.3 Stentys SA Absorbable Drug Eluting Coronary Stent System Product and Services
    • 2.7.4 Stentys SA Absorbable Drug Eluting Coronary Stent System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Stentys SA Recent Developments/Updates
  • 2.8 Sino Medical
    • 2.8.1 Sino Medical Details
    • 2.8.2 Sino Medical Major Business
    • 2.8.3 Sino Medical Absorbable Drug Eluting Coronary Stent System Product and Services
    • 2.8.4 Sino Medical Absorbable Drug Eluting Coronary Stent System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Sino Medical Recent Developments/Updates
  • 2.9 Beijing ESSEN Technology
    • 2.9.1 Beijing ESSEN Technology Details
    • 2.9.2 Beijing ESSEN Technology Major Business
    • 2.9.3 Beijing ESSEN Technology Absorbable Drug Eluting Coronary Stent System Product and Services
    • 2.9.4 Beijing ESSEN Technology Absorbable Drug Eluting Coronary Stent System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Beijing ESSEN Technology Recent Developments/Updates
  • 2.10 Beijing Advanced Medical Technologies
    • 2.10.1 Beijing Advanced Medical Technologies Details
    • 2.10.2 Beijing Advanced Medical Technologies Major Business
    • 2.10.3 Beijing Advanced Medical Technologies Absorbable Drug Eluting Coronary Stent System Product and Services
    • 2.10.4 Beijing Advanced Medical Technologies Absorbable Drug Eluting Coronary Stent System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Beijing Advanced Medical Technologies Recent Developments/Updates
  • 2.11 LifeTech Scientific Corporation
    • 2.11.1 LifeTech Scientific Corporation Details
    • 2.11.2 LifeTech Scientific Corporation Major Business
    • 2.11.3 LifeTech Scientific Corporation Absorbable Drug Eluting Coronary Stent System Product and Services
    • 2.11.4 LifeTech Scientific Corporation Absorbable Drug Eluting Coronary Stent System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 LifeTech Scientific Corporation Recent Developments/Updates
  • 2.12 MicroPort Scientific Corporation
    • 2.12.1 MicroPort Scientific Corporation Details
    • 2.12.2 MicroPort Scientific Corporation Major Business
    • 2.12.3 MicroPort Scientific Corporation Absorbable Drug Eluting Coronary Stent System Product and Services
    • 2.12.4 MicroPort Scientific Corporation Absorbable Drug Eluting Coronary Stent System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 MicroPort Scientific Corporation Recent Developments/Updates
  • 2.13 Yilson Medical Technology
    • 2.13.1 Yilson Medical Technology Details
    • 2.13.2 Yilson Medical Technology Major Business
    • 2.13.3 Yilson Medical Technology Absorbable Drug Eluting Coronary Stent System Product and Services
    • 2.13.4 Yilson Medical Technology Absorbable Drug Eluting Coronary Stent System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 Yilson Medical Technology Recent Developments/Updates
  • 2.14 Lepu Medical Technology
    • 2.14.1 Lepu Medical Technology Details
    • 2.14.2 Lepu Medical Technology Major Business
    • 2.14.3 Lepu Medical Technology Absorbable Drug Eluting Coronary Stent System Product and Services
    • 2.14.4 Lepu Medical Technology Absorbable Drug Eluting Coronary Stent System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 Lepu Medical Technology Recent Developments/Updates
  • 2.15 Shandong Hua'an Biotechnology
    • 2.15.1 Shandong Hua'an Biotechnology Details
    • 2.15.2 Shandong Hua'an Biotechnology Major Business
    • 2.15.3 Shandong Hua'an Biotechnology Absorbable Drug Eluting Coronary Stent System Product and Services
    • 2.15.4 Shandong Hua'an Biotechnology Absorbable Drug Eluting Coronary Stent System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.15.5 Shandong Hua'an Biotechnology Recent Developments/Updates

3 Competitive Environment: Absorbable Drug Eluting Coronary Stent System by Manufacturer

  • 3.1 Global Absorbable Drug Eluting Coronary Stent System Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Absorbable Drug Eluting Coronary Stent System Revenue by Manufacturer (2020-2025)
  • 3.3 Global Absorbable Drug Eluting Coronary Stent System Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Absorbable Drug Eluting Coronary Stent System by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Absorbable Drug Eluting Coronary Stent System Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Absorbable Drug Eluting Coronary Stent System Manufacturer Market Share in 2024
  • 3.5 Absorbable Drug Eluting Coronary Stent System Market: Overall Company Footprint Analysis
    • 3.5.1 Absorbable Drug Eluting Coronary Stent System Market: Region Footprint
    • 3.5.2 Absorbable Drug Eluting Coronary Stent System Market: Company Product Type Footprint
    • 3.5.3 Absorbable Drug Eluting Coronary Stent System Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Absorbable Drug Eluting Coronary Stent System Market Size by Region
    • 4.1.1 Global Absorbable Drug Eluting Coronary Stent System Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Absorbable Drug Eluting Coronary Stent System Consumption Value by Region (2020-2031)
    • 4.1.3 Global Absorbable Drug Eluting Coronary Stent System Average Price by Region (2020-2031)
  • 4.2 North America Absorbable Drug Eluting Coronary Stent System Consumption Value (2020-2031)
  • 4.3 Europe Absorbable Drug Eluting Coronary Stent System Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Absorbable Drug Eluting Coronary Stent System Consumption Value (2020-2031)
  • 4.5 South America Absorbable Drug Eluting Coronary Stent System Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Absorbable Drug Eluting Coronary Stent System Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Absorbable Drug Eluting Coronary Stent System Sales Quantity by Type (2020-2031)
  • 5.2 Global Absorbable Drug Eluting Coronary Stent System Consumption Value by Type (2020-2031)
  • 5.3 Global Absorbable Drug Eluting Coronary Stent System Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Absorbable Drug Eluting Coronary Stent System Sales Quantity by Application (2020-2031)
  • 6.2 Global Absorbable Drug Eluting Coronary Stent System Consumption Value by Application (2020-2031)
  • 6.3 Global Absorbable Drug Eluting Coronary Stent System Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Absorbable Drug Eluting Coronary Stent System Sales Quantity by Type (2020-2031)
  • 7.2 North America Absorbable Drug Eluting Coronary Stent System Sales Quantity by Application (2020-2031)
  • 7.3 North America Absorbable Drug Eluting Coronary Stent System Market Size by Country
    • 7.3.1 North America Absorbable Drug Eluting Coronary Stent System Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Absorbable Drug Eluting Coronary Stent System Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Absorbable Drug Eluting Coronary Stent System Sales Quantity by Type (2020-2031)
  • 8.2 Europe Absorbable Drug Eluting Coronary Stent System Sales Quantity by Application (2020-2031)
  • 8.3 Europe Absorbable Drug Eluting Coronary Stent System Market Size by Country
    • 8.3.1 Europe Absorbable Drug Eluting Coronary Stent System Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Absorbable Drug Eluting Coronary Stent System Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Absorbable Drug Eluting Coronary Stent System Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Absorbable Drug Eluting Coronary Stent System Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Absorbable Drug Eluting Coronary Stent System Market Size by Region
    • 9.3.1 Asia-Pacific Absorbable Drug Eluting Coronary Stent System Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Absorbable Drug Eluting Coronary Stent System Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Absorbable Drug Eluting Coronary Stent System Sales Quantity by Type (2020-2031)
  • 10.2 South America Absorbable Drug Eluting Coronary Stent System Sales Quantity by Application (2020-2031)
  • 10.3 South America Absorbable Drug Eluting Coronary Stent System Market Size by Country
    • 10.3.1 South America Absorbable Drug Eluting Coronary Stent System Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Absorbable Drug Eluting Coronary Stent System Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Absorbable Drug Eluting Coronary Stent System Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Absorbable Drug Eluting Coronary Stent System Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Absorbable Drug Eluting Coronary Stent System Market Size by Country
    • 11.3.1 Middle East & Africa Absorbable Drug Eluting Coronary Stent System Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Absorbable Drug Eluting Coronary Stent System Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Absorbable Drug Eluting Coronary Stent System Market Drivers
  • 12.2 Absorbable Drug Eluting Coronary Stent System Market Restraints
  • 12.3 Absorbable Drug Eluting Coronary Stent System Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Absorbable Drug Eluting Coronary Stent System and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Absorbable Drug Eluting Coronary Stent System
  • 13.3 Absorbable Drug Eluting Coronary Stent System Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Absorbable Drug Eluting Coronary Stent System Typical Distributors
  • 14.3 Absorbable Drug Eluting Coronary Stent System Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Absorbable Drug Eluting Coronary Stent System market size was valued at US$ 6016 million in 2024 and is forecast to a readjusted size of USD 7972 million by 2031 with a CAGR of 4.2% during review period.
    In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
    The Absorbable Drug-Eluting Coronary Stent System is an innovative medical device designed to treat coronary artery disease, especially for the recanalization of narrowed or blocked blood vessels. Unlike traditional metal drug-eluting stents, BVS can be gradually absorbed by the human body after completing its supporting function, restoring the natural state and elasticity of the blood vessels. This stent is made of biocompatible materials such as polylactic acid, and releases anti-proliferative drugs within a few months after implantation to prevent restenosis of the blood vessels.
    This report is a detailed and comprehensive analysis for global Absorbable Drug Eluting Coronary Stent System market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Absorbable Drug Eluting Coronary Stent System market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Absorbable Drug Eluting Coronary Stent System market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Absorbable Drug Eluting Coronary Stent System market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global Absorbable Drug Eluting Coronary Stent System market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Absorbable Drug Eluting Coronary Stent System
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Absorbable Drug Eluting Coronary Stent System market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Boston Scientific, Medtronic, Abbott, B.Braun, BD, Biotronik AG, Stentys SA, Sino Medical, Beijing ESSEN Technology, Beijing Advanced Medical Technologies, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Absorbable Drug Eluting Coronary Stent System market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Rapamycin Eluting Stent
    Everolimus Eluting Stent
    Others
    Market segment by Application
    Hospitals
    Clinic
    Others
    Major players covered
    Boston Scientific
    Medtronic
    Abbott
    B.Braun
    BD
    Biotronik AG
    Stentys SA
    Sino Medical
    Beijing ESSEN Technology
    Beijing Advanced Medical Technologies
    LifeTech Scientific Corporation
    MicroPort Scientific Corporation
    Yilson Medical Technology
    Lepu Medical Technology
    Shandong Hua'an Biotechnology
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Absorbable Drug Eluting Coronary Stent System product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Absorbable Drug Eluting Coronary Stent System, with price, sales quantity, revenue, and global market share of Absorbable Drug Eluting Coronary Stent System from 2020 to 2025.
    Chapter 3, the Absorbable Drug Eluting Coronary Stent System competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Absorbable Drug Eluting Coronary Stent System breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Absorbable Drug Eluting Coronary Stent System market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Absorbable Drug Eluting Coronary Stent System.
    Chapter 14 and 15, to describe Absorbable Drug Eluting Coronary Stent System sales channel, distributors, customers, research findings and conclusion.

    Buy now